GE HealthCare Technologies Inc. $GEHC Shares Bought by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 95.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 704,344 shares of the company’s stock after purchasing an additional 344,852 shares during the quarter. Tocqueville Asset Management L.P.’s holdings in GE HealthCare Technologies were worth $45,085,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Western Wealth Management LLC increased its position in shares of GE HealthCare Technologies by 2.4% in the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock valued at $430,000 after buying an additional 125 shares in the last quarter. United Community Bank lifted its position in shares of GE HealthCare Technologies by 10.2% during the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock valued at $116,000 after buying an additional 130 shares in the last quarter. Parkside Financial Bank & Trust lifted its position in shares of GE HealthCare Technologies by 3.9% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock valued at $293,000 after buying an additional 134 shares in the last quarter. Quadrant Capital Group LLC grew its stake in GE HealthCare Technologies by 1.1% in the 4th quarter. Quadrant Capital Group LLC now owns 12,557 shares of the company’s stock valued at $1,030,000 after acquiring an additional 140 shares during the period. Finally, Mount Vernon Associates Inc. MD grew its stake in GE HealthCare Technologies by 0.8% in the 1st quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company’s stock valued at $1,293,000 after acquiring an additional 144 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $74.62 on Thursday. The firm has a 50-day simple moving average of $66.22 and a 200-day simple moving average of $69.60. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92. The stock has a market capitalization of $33.71 billion, a price-to-earnings ratio of 17.11, a price-to-earnings-growth ratio of 2.10 and a beta of 0.69. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09. The firm had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. GE HealthCare Technologies’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.06 earnings per share. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Friday, July 24th were given a $0.035 dividend. The ex-dividend date was Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.21%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on GEHC. Piper Sandler restated a “buy” rating on shares of GE HealthCare Technologies in a research report on Wednesday, July 29th. The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Oppenheimer reissued an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. UBS Group raised their price target on shares of GE HealthCare Technologies from $67.00 to $73.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. Finally, Stifel Nicolaus set a $80.00 price objective on GE HealthCare Technologies in a report on Wednesday, April 29th. Ten analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Hold” and a consensus price target of $77.73.

Insider Activity

In related news, Director Kevin Lobo purchased 10,000 shares of the business’s stock in a transaction that occurred on Friday, May 22nd. The stock was purchased at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the acquisition, the director owned 14,363 shares in the company, valued at $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. 0.36% of the stock is owned by company insiders.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.